Effingham, IL-(Effingham Radio)- The world’s first lung cancer vaccine trial is underway in seven countries, including the U.S. The others are the UK, Germany, Hungary, Poland, Spain and Turkey. It’s a Phase One clinical trial that uses an mRNA vaccine, similar to the COVID-19 vaccines.
BioNTech developed it to treat non-small cell lung cancer which is the most common type of lung cancer. One-hundred-thirty patients are enrolled in the trial and are receiving the vaccine alongside immunotherapy.
Copyright © 2024 TTWN Media Networks Inc.
Comments